[1] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[2] |
XUE Tian, SHENG Dong, YAN Wanhui, JIANG Xiangnan, LI Huan’ge, LI Xiaoqiu.
Prognostic factors of follicular lymphoma
[J]. China Oncology, 2020, 30(5): 388-393.
|
[3] |
LIN Jinyi , WANG Yan , HOU Huiping , ZHOU Yuhong , LIU Tianshu , CHENG Leilei .
Clinical value of soluble ST2 in patients with soft tissue sarcomas: a single center cross-sectional study
[J]. China Oncology, 2020, 30(12): 996-1001.
|
[4] |
LI Yuan , GU Wenxian , ZHOU Xiaoli , GENG Xiang , SUN Yangyang .
Clinicopathological observation and prognostic analysis of pure mucinous breast carcinoma with micropapillary pattern
[J]. China Oncology, 2020, 30(11): 897-904.
|
[5] |
SUN Yangyang,GENG Xiang,ZHOU Xiaoli,WANG Gengfang,GU Wenxian,ZHANG Xudong .
Clinicopathologic observation and prognostic factor analysis of primary gastric diffuse large B-cell lymphoma
[J]. China Oncology, 2019, 29(9): 715-722.
|
[6] |
HUANG Limin, LEI Zhu, ZHANG Yu, LI Yong, HOU Jing, XU Zhong, CAO Hui, WANG Tao, YANG Jie.
Clinical evaluation of postoperative residual tumor by 3D-ASL magnetic resonance imaging in high-grade glioma
[J]. China Oncology, 2019, 29(11): 875-879.
|
[7] |
LUO Chunli, LI Zhiping.
Advances in molecular targeted therapies for soft tissue sarcomas
[J]. China Oncology, 2019, 29(10): 824-831.
|
[8] |
YUAN Yuan, SHEN Zan.
Retrospective analysis of clinical differences and prognostic factors in 32 patients with maxillofacial osteosarcoma
[J]. China Oncology, 2018, 28(2): 134-139.
|
[9] |
LIU Xin, ZHANG Xiaowei, WANG Huijie, et al.
Pegylated liposomal doxorubincin combined with ifosfamide as first-line treatment for patients with advanced or metastatic soft tissue sarcoma
[J]. China Oncology, 2017, 27(9): 687-692.
|
[10] |
SHI Xiao, JI Qinghai.
Progress and prospect of TNM staging system of head and neck squamous cell carcinoma
[J]. China Oncology, 2017, 27(6): 510-515.
|
[11] |
SONG Yang, LIU Liyang, LI Fenghu, et al.
Expression of HER-2 in 720 cases of breast cancer patients in Guizhou province and retrospective analysis of anti-HER-2 treatment
[J]. China Oncology, 2017, 27(11): 884-889.
|
[12] |
LV Bo, CHEN Yun, LI Yunhai, et al.
Outcomes and clinical prognostic factors for elderly patients with esophageal squamous cell carcinoma treated after definitive chemoradiotherapy
[J]. China Oncology, 2015, 25(3): 217-221.
|
[13] |
LI Jian, YE Ding-wei, YAO Xu-dong, ZHANG Shi-lin, DAI Bo, ZHANG Hai-liang, SHEN Yi-jun, ZHU Yao, SHI Guo-hai, ZHU Yi-ping, MA Chun-guang, QIN Xiaojian, LIN Guo-wen, XIAO Wen-jun.
The value of preoperative platelet to lymphocyte ratio in predicting of clinical stage and prognosis in upper tract urothelial carcinoma
[J]. China Oncology, 2013, 23(6): 457-461.
|
[14] |
GAO Jie, ZHANG Hua, ZHAO Hua-rong, MAO Rui, XIAO Lei, AI Si-ke-er, WEN Hao, BAO Yong-xing.
Analysis of prognosis and influencing factors of 246 Uyghur patients with primary hepatic carcinoma in Xinjiang region
[J]. China Oncology, 2013, 23(5): 362-369.
|